Abstract. Complementary metal oxide semiconductor (CMOS) image sensors have received great attention for their high efficiency in biological applications. The present work describes a CMOS image sensor-based whole blood glucose monitoring system through a point-of-care (POC) approach. A simple poly-ethylene terephthalate (PET) chip was developed to carry out the enzyme kinetic reaction at various concentrations (110-586 mg∕dL) of mouse blood glucose. In this technique, assay reagent is immobilized onto amine functionalized silica (AFSiO 2 ) nanoparticles as an electrostatic attraction in order to achieve glucose oxidation on the chip. The assay reagent immobilized AFSiO 2 nanoparticles develop a semi-transparent reaction platform, which is technically a suitable chip to analyze by a camera module. The oxidized glucose then produces a green color according to the glucose concentration and is analyzed by the camera module as a photon detection technique; the photon number decreases when the glucose concentration increases. The combination of these components, the CMOS image sensor and enzyme immobilized PET film chip, constitute a compact, accurate, inexpensive, precise, digital, highly sensitive, specific, and optical glucose-sensing approach for POC diagnosis.
Introduction
Diabetes mellitus is a common health issue in most developed and developing countries. As monitoring of glucose is the most effective solution for standard diabetes care, frequent monitoring can reduce disease severities, secondary complications, related mortalities, and aid in maintaining the body's insulin level. 1 Clinical analysis is the best way to accurately determine the level of blood glucose. However, as multiple glucose analyses and rapid monitoring are required, self-monitoring of glucose levels is preferred. In this respect, many glucose monitors have been developed using various approaches, such as enzymatic analysis, electrochemical measurement, and continuous glucose measurement through both invasive and noninvasive methods in order to satisfy the demand. Enzymatic analysis is the most valuable analytical assay due to its high specificity; it does not respond to any other physiological fluids. Moreover, optical glucose sensors of porous gel sensor, 2 optical strip sensor, 3 and nanoprism sensor 4 have been reported as effective sensors with enzymatic analysis. However, their complication is that the readout of the results is analog. Hence, electrochemical-based amperometric glucose sensors are the most appealing type of sensors due to their user-friendly and digital output. However, interferences with nonspecific electroactive particles combined with complications related to signal conversion between the enzyme and mediator are two disadvantages of the sensors. 5, 6 Importantly, accurate and user-friendly glucose monitoring is essential to control diabetic complications. Accordingly, we were motivated to develop an enzymatic glucose sensor with a digital read out signal. The present research group found that CMOS image sensor-based whole blood glucose analysis is one of the most efficient methods due to its digital output, real-time monitoring and high availability in mobile phone cameras, which is a huge added advantage. Usually, the CMOS image sensors use as a digital camera, microprocessors, and sensor elements; 7 nowadays, the CMOS sensors participate in the generation of the protein/peptide array and DNA array. [8] [9] [10] Also, we have successfully accomplished CMOS image sensor-based antigen-antibody interactions. [11] [12] [13] [14] In addition, CMOS image sensors employing various glucose monitoring methods, including continuous glucose monitoring method, 15, 16 enzymatic glucose monitoring method, 17, 18 and thermal-based glucose monitoring, 19 operate at the in vitro and in vivo levels. In addition, smartphones have proved efficient for calorimetric analysis. Therein, Oncescu et al. demonstrated smartphone-based biomarker monitoring for hydration, electrolyte loss, and enamel decalcification using sweat and saliva. 20 A light-emitting diode (LED) array integrated smartphone camera has been utilized as a hand-held microplate reader for enzyme-linked immunosorbent assays (ELISA). 21 Moreover, a smartphone camera analyzed the color intensity of a 3-D reaction platform to quantify the glucose level; the analysis takes 7 min to read out the data. 22 Also, our previous study performed smartphone camera-based mouse plasma glucose monitoring as a photon-detection technique. 18 Such positive outcomes have motivated us to continue the study with whole blood glucose analysis. According to the research report, nanomaterials and microparticles play major roles in electrochemical and enzymatic glucose sensors. 23 Similarly, we have utilized silica nanoparticles for enzymatic glucose measurement due to their chemical inertness, optical transparency, low temperature encapsulation, thermal stability, and biocompatibility. 24 Particularly, glucose oxidase (GOX) enzyme and chromogen could be immobilized on amine-functionalized silica nanoparticles (AFSiO 2 ) through electrostatic attraction. 25, 26 In the present study, a CMOS image sensor was used as a bioanalytical device for the measurement of blood glucose levels. For the analysis, 28 mouse whole blood samples were applied to the poly-ethylene terephthalate (PET) chip, and filtered plasma was flowed over the reaction area. The oxidized glucose produced the green color based on the glucose concentration. 27 The CMOS image sensor that measures the glucose level based on the color intensity is an original point that differentiates this work from others. In addition, the study demonstrated fabrication of a PET chip that is technically suitable for a CMOS sensor-based monitoring system, synthesis of AFSiO 2 nanoparticles, immobilization of assay reagent on PET film, enzyme stability and activity, blood plasma separation that is reproducible and user friendly. As a result, a CMOS image sensor-based real-time whole blood glucose monitoring system reached the clinical standard. A wide range of photophysical techniques such as UV-spectral absorbance, dynamic light scattering (DLS), Fourier transform-infrared spectroscopy (FTIR), x-ray diffraction (XRD), and field emission scanning electron microscopic (FE-SEM) imagery were used to characterize various aspects, including nanoparticle size and distribution, enzyme immobilized AFSiO 2 nanoparticles, absorbance of assay reagent immobilized AFSiO 2 nanoparticles, and differences between bare and enzyme-immobilized chips. Positive outcomes motivated the fabrication of a PET chip for enzyme kinetic blood glucose analysis using a CMOS image sensor. This study provides a simple and precise approach for a blood glucose monitoring system by point-of-care (POC) approach.
Materials and Methods

CMOS Image Sensor and Instrumentation
A CMOS image sensor (Sponsored from Silicon File Technologies) is an electronic device that converts electrons into digital numbers. In the present experiment, a NOON0PC30L, 110,000 active single chip CMOS image sensor was used. The sensor contains 367 × 314 multi pixel photon arrays and is connected to a 10-bit analog-to-digital converter (ADC). The photodiode absorbs photons from living room lights and they are converted as electrons into a digital number by the ADC. Moreover, FE-SEM (JEOL-ISM-7500F; JEOL, Tokyo, Japan) images and the DLS method (Malvern Instruments Korea, Seoul, Republic of Korea) were used to confirm the average particle size of AFSiO 2 nanoparticles and their distribution. Electrophoretic light scattering spectrophotometer (ELS-800; Japan) was used to measure the zeta potential or overall surface charge of the AFSiO 2 nanoparticles. Furthermore, a UV-spectral study (Carry Win Spectrophotometer) determined the absorbance of the AFSiO 2 nanoparticles before and after assay reagent immobilization and oxidation. Three individual samples were used for each spectral analysis at 25°C. XRD analysis (Model D/Max-2200; Rigaku, Woodlands, Texas) was used to identify the crystallites of the synthesized AFSiO 2 nanoparticles and the reacted sample. Functional groups were recorded by an FTIR spectroscopy (TENSOR 27 instrument, Bruker Optics, Alexandria, NSW, Australia) for AFSiO 2 nanoparticles before and after enzyme immobilization and oxidation.
Synthesis of AFSiO 2 Nanoparticles
For AFSiO 2 nanoparticle synthesis, 6.16 ml of ammonia (NH 3 ), 500 μl of 3-aminopropyl triethoxysilane (APTES), and 4.48 ml of distilled water (DI) were added to 6.95 ml of ethanol and then stirred for 1 h using a magnetic stirrer. Then 2.5 ml of TEOS was applied to the mixture drop wise using an injection pump (flow rate: 830 μl∕ min) and it was stirred for 24 h. The silica colloids were recovered by high speed centrifugation. Then the solutions were dialyzed with ethanol and deionized (DI) water to remove unreactive materials. The collected nanoparticles were mixed with assay reagent before being applied to the hydrophilic PET film.
Preparation of Assay Reagent
Glucose oxidase (GOD) (100;000 units∕g), peroxidase (POD) (300 units∕g), and 35 mM chromogen of 2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) were purchased from Sigma Aldrich, and reagents were prepared at their respective concentrations using standard laboratory procedures. All solutions were prepared and stored in the refrigerator until use. The enzymes and chromogen were mixed at 2:2:1 volume ratios. The required amount (15 μl) of assay reagent was added onto AFSiO 2 nanoparticles to induce the interaction between the assay reagent and AFSiO 2 nanoparticles.
Blood Collection from Mouse
Eight-week-old male C57BL/6J mice were purchased from Charles River Laboratories, Japan. The mice were housed under controlled temperature (22 AE 2°C) and 12 h light/dark cycle with free access to water and a regular diet (PicoLab Rodent Diet 20, #5053, LabDiet). After 1 week acclimation period, mice were divided into two groups and fed either a regular diet or a 60% high fat diet (HFD) (D12492, Research Diet) for 4 weeks. At 13 weeks of age, to test various levels of blood glucose, glucose (2 g∕kg body weight) was intraperitoneally administrated in 16 h overnight-fasting mice and blood was collected from the tail vein at 0, 15, 30, 60, 90, 120, 140, and 160 min (n ¼ 3). A lower concentration of glucose analysis was carried out with 20 h fasting mice and 5-h fasting mice. Glucose concentration was analyzed using 5 μl whole blood by a glucose oxidase method on a GM9 glucose analyzer II (Analox, London) and CMOS-based measurements. All the experiments were performed in compliance with the relevant laws and institutional guidelines and also in accordance with the institutional Center of Animal Care and Use Committee of Lee Gil Ya Cancer and Diabetes Institute, Gachon University. For the CMOS analysis, 28 mice having different glucose concentrations were used for glucose analysis. The whole blood collection schedule and concentrations of glucose are given in Table 1 .
Chip Fabrication for Glucose Analysis
A simple disposable chip was fabricated by using hydrophilic PET film. Sample pad and plasma separation membranes were used to filter the plasma from whole blood, and the absorption pad was used to absorb excess plasma or an oxidized sample. The 10 mm × 4 mm size of the reaction area with a capacity of 15 μl was developed in the bottom layer of the PET film (20 mm × 8 mm). Assay reagent immobilized on AFSiO 2 nanoparticles was dispensed over the reaction area of the hydrophilic PET film, which was stored in the refrigerator until use. To fabricate the chip, a 10 mm × 8 mm size of a hydrophilic PET film was fixed over the bottom layer of the PET film, as shown in Fig. 1 . Both lateral edges of the top layer were strongly fixed on the bottom layer of the PET film by a double-sided adhesive layer, which increases the capillary action. This was followed by a 4 mm × 8 mm absorption pad, which was fixed at the right end of the chip, and was made of cellulose fiber with a high absorption capacity. One edge of the plasma separation membrane (6 mm × 8 mm) was fixed on the left side of the bottom layer while the other end overlapped the top layer of the PET film. Four edges of the separation layer were pasted on the PET film. The plasma separation membrane gently touched the bottom layer for easy and rapid sample flow to the reaction area. The 6 mm × 8 mm sample pad was fixed and pasted at the edge of the bottom layer. A schematic illustration of the glucose chip is shown in Fig. 1 , layer by layer. Previously, various types of glucose chips were prepared for whole blood glucose analysis that exhibited filtration defects, time consuming kinetic reaction, and less photon sensitivity. Finally, a chip was fabricated without any defects along with a high sensitivity to the respective analysis method.
Glucose Assay in Disposable Poly-Ethylene Terephthalate Chip
For the glucose assay, assay reagent immobilized AFSiO 2 nanoparticles (15 μl) were dispensed over the reaction area before fixing the top layer of the PET film. A hydrophilic PET film ensured uniform immobilization over the entire reaction area. SiO 2 absorbed the water content of the assay reagent, and the amine group kept the enzymes from leaching. The enzyme immobilized nanoparticles helped to develop the chip as a semitransparent substrate, which eradicates the scattering effect and produces consistent photon transmission. The fully fabricated chip was kept in a refrigerator until use. Twenty-eight whole blood samples were collected from normal and HFD mice and applied to individual glucose chips. Cell debris and blood cells were captured by the sample pad and plasma separation membrane, respectively. The plasma separation membrane could filter about 90% of the plasma, which was more pure Note: Blood was not collected from HRD mice at 5 h fasting and after feeding -140 min (fasting blood glucose: FBG; feeding blood glucose: FeBG) Fig. 1 Fabrication of hydrophilic poly-ethylene terephthalate (PET) film chip for whole blood glucose analysis. Assay reagent immobilized amine functionalized silica (AFSiO 2 ) nanoparticles are coated on the bottom layer of the PET film and the reaction area is covered with a top layer for capillary action. Then the plasma separation membrane, sample pad, and absorption pad arer fixed to make a fully fabricated chip. Each membrane has been fixed by a double sided adhesive layer.
than that obtained by centrifugation. Filtered plasma flowed onto the bottom layer of the chip as well as over the reaction area due to capillary action. Plasma glucose reacted well with the assay reagent for 1 to 2 min. An excess amount of sample flowed over the chip and was absorbed by the absorption pad. Each concentration of glucose produced a different intensity of green color that could be observed by the naked eye. Each chip was quantitatively analyzed by the CMOS image sensor.
Biochemical Analysis for Enzyme Activity and Stability to the Chip
The enzyme activity and stability of the chip was analyzed by a CMOS image sensor. To determine the specificity and sensitivity, different aqueous sugars were analyzed in the chip including galactose, sucrose, and lactose. Analyses were independently performed on the chip three times. 3 Results and Discussion
Surface Charge and Surface Morphological Analysis
Assay reagents immobilized on AFSiO 2 nanoparticles as electrostatic interactions and were spread over the hydrophilic PET film easily and uniformly. The interactions between AFSiO 2 nanoparticles and assay regents were confirmed by the zeta potential. The zeta potential has shown around þ27 mV for AFSiO 2 nanoparticles since the presence of a positively charged amine group was found on the surface and the zeta potential decreased to −20 mV for negatively charged assay reagent. FE-SEM analysis was carried out to find the fundamental characterization of surface morphology of the chip. Thereby, AFSiO 2 nanoparticles, enzymeimmobilized nanoparticles, and oxidized nanoparticles were observed by SEM, as shown in Fig. 2. Figures 2(a)-2(c) show the uniform distribution of AFSiO 2 nanoparticles that adsorbed as two layers on PET film. The particle size was around 150 nm in each film. The reaction area of the chip images is presented in Figs. 2(e)-2(g), which proves the differences between AFSiO 2 nanoparticles and assay reagent immobilized nanoparticles. The enzyme immobilized film had a thin layer formation on AFSiO 2 nanoparticles as well as a thick layer formation after glucose oxidation. The FE-SEM images confirmed the interactions between assay reagent-AFSiO 2 nanoparticles and proved their adhesion over the film. Moreover, Figs. 2(d) and 2(h) show the DLS analysis at 633 nm and a scattering angle of 90°C. The data confirm a particle size of 140 AE 21 nm for AFSiO 2 nanoparticles, and the size increased to 180 AE 32 nm after enzyme immobilization on AFSiO 2 nanoparticles. The DLS data proved the assay reagent immobilization on AFSiO 2 nanoparticles by particle size increment.
Ultraviloet-Spectral Analysis
Figure 3(i) shows the UV-visible absorbance spectrum of AFSiO 2 nanoparticles, assay reagent immobilized nanoparticles, and oxidized glucose. The analysis was carried out to find the level of interaction between the assay reagent, AFSiO 2 nanoparticles, and oxidized glucose which displayed an absorbance in the region from 200 to 800 nm. The absorption curve for AFSiO 2 nanoparticles showed a hump at 210 nm due to the localized surface plasmon of nanosized SiO 2 particles. The assay reagent showed two peaks at 350 and 400 nm; also, the assay reagent immobilized AFSiO 2 nanoparticles showed broader peaks at 400 nm and the absence of peaks at 350 nm. There was a peak shift to 405 nm, and additional peaks developed at 560 nm after glucose oxidation. This result confirms the effective interaction between the assay reagent and AFSiO 2 nanoparticles; it also proves that the interactions of the assay reagent immobilized AFSiO 2 nanoparticles were not influenced by the quality of glucose oxidation on the chip. Moreover, AFSiO 2 nanoparticles have various biological applications such as optical sensing, bio adsorption, and biocompatibility.
Fourier Transform-Infrared Spectroscopy Structural Analysis
Structural information and interactions were studied for bare hydrophilic PET film, an AFSiO 2 nanoparticle coated film, the assay reagent immobilized AFSiO 2 film, and oxidized glucose films by FTIR, which are shown in Fig. 3 (ii). Generally, hydrophilic PET film peak absorption energy considerably increased at ∼500-1750 cm −1 , including a benzene ring (721), primary alcohol (1085 and 1013), and hybrid sp2 C─O [1233 and C═O (1707)]. Absorbance signals at 1546 cm −1 were assigned to the asymmetrical stretching vibration of COO─.
27,29
The 2-Methacryloyloxyethyl phosphorylcholine unit featured one phosphor atom, an organic acid ─COOH, and an inorganic acid P─O on both sides of the molecules structures, directly improving the hydrophilicity. 30 The spectrum of the hydrophilic PET film showed almost the same characteristic bands as the present study. The peak at 1060 cm −1 indicates Si─O─Si asymmetric stretching vibrations, whereas 795 cm −1 was assigned to Si─O─Si symmetric stretching vibrations. The peak at 937 cm −1 was assigned to ν (≡Si─OH) of a free silanol group. [31] [32] [33] [34] Moreover, a new sharp peak was identified at 2965 cm −1 , which indicates the presence of AFSiO 2 nanoparticles. 33 Figure 3 (ii) c almost shows the same peak as the AFSiO 2 nanoparticles, and new peaks at 1563 and 1613 cm −1 indicate assay reagent immobilized successfully on AFSiO 2 . New sharp and moderate peaks appeared at 1556 and 1654 cm -1 , which seem to indicate oxidized plasma glucose and other substances in the plasma. The assay reagent immobilized chip was analyzed after 20 days to confirm the stability of the assay reagent. There was no alteration of the characteristic peaks in the respective image of Fig. 3 (ii) e, which supports chip stability. The structural information and interactions on bare hydrophilic PET film, AFSiO 2 nanoparticle coated film, enzyme immobilized chip, oxidized glucose chip, and chip stability results prove that there was no alteration in their characteristic peak after interactions on the PET film, which does not affect the glucose oxidation. All these characterization studies have proven the AFSiO 2 nanoparticle chip suitable for CMOS image-based whole blood glucose sensing. The intensive characteristic absorption peaks were observed in the liquid stage, while a new sharp peak appeared in the liquid stage of the sample at 2985 cm −1 , indicating the amine groups in the SiO 2 nanoparticle suspension. 35 Moreover, sharp peaks appeared at 2960 and 2893 cm -1 , which indicate assay reagent immobilized on AFSiO 2 nanoparticles in molecular water (data not shown). Based on these functional groups, we were able to understand the structural vibrations of AFSiO 2 nanoparticles, enzyme immobilized AFSiO 2 , and oxidized glucose; their functional groups were not affected when bonded on the chip. Figure 4 shows the XRD patterns of the hydrophilic PET film before and after enzyme immobilized films. XRD patterns of the hydrophilic PET film show a broader peak in the range of 2θ ¼ 23 deg and 25 deg, which can be allotted to the semi-crystalline structure of the PET film or an extrusion process in the production of the PET film. 36 A sharp peak occurs in the range of 2θ ¼ 23 deg and 25 deg, indicating the microcrystalline structure of the AFSiO 2 nanoparticles, and the intensity decreased gradually after assay reagent immobilization. The broader peaks identified at 2θ ¼ 23 deg and 25 deg indicate semi-crystallites for enzyme-immobilized and oxidized glucose substrates, which show that the immobilized enzyme did not alter the structure of the AFSiO 2 nanoparticles. 37 The results corroborated other related studies on enzyme immobilized AFSiO 2 nanoparticles adsorbed to PET film and oxidized glucose.
X-Ray Diffraction Analysis
Photon Analysis by Smartphone Camera Module
Suitable chip fabrication is an important part to this study. The hydrophilic PET film surface was suitable for coupling with the AFSiO 2 nanoparticle layer. Amine groups could bind the negatively charged enzymes via the electrostatic interactions that helped to develop the technically suitable chip for analysis by CMOS image sensor. Further, the characterization study proves the AFSiO 2 nanoparticle-based PET chip is suitable for glucose analysis. The CMOS image sensor analyzed the chip before and after glucose oxidation. Each CMOS image sensor contains a single photodiode to absorb the photons and convert them into the electrical energy via the photo electric effect. The electrical energy is converted into a digital number, which is directly proportional to the number of photon hits on sensor surface. Thereby, the photon number reduces any object exposed on the sensor. This simple concept creates the impacts on the POC glucose monitoring. Before measurement, the calibration value was fixed in the CMOS image sensor by adjusting the exposure time and analog gain value instead of by maximizing the background light intensity. Then an assay reagent added chip was exposed on the sensor, and the value was fixed as a reference value (175 A.U). In the glucose reaction, plasma glucose reacted with GOX, producing gluconic acid and H 2 O 2 . Following this, H 2 O 2 reacted with 2, 2'-azino-bis (3-ethylbenzothiazoline-6-sulphonic acid) (ABTS) in the presence of POD. Oxidized ABTS produced a green color product based on the glucose concentration through the enzyme kinetic reaction, which is shown in Fig. 5(a) . Previously, our group carried out the glucose analysis from 3 mg∕dL to 1000 mg∕dL successfully using the aforementioned reaction that proved the lower and upper limits of glucose detection. 17 Figure 5(b) shows the schematic of glucose oxidation on the PET chip and monitoring by the CMOS image sensor as a photon-detection technique. For the analysis, 28 PET film chips were analyzed, and each chip produced a different color intensity based on the glucose concentration. Variations in color intensity at different glucose concentrations are shown in Fig. 5(c) . The lower the concentration of glucose, the paler the color after oxidation with ABTS, and the color intensity increased with a higher concentration of glucose. Similarly, different concentrations of glucose produce different photon numbers based on the color intensity. A lower color intensity allowed the passing of more photons, and a higher color intensity allowed the passing of fewer photons. Thereby, the photon value decreased when the glucose concentration increased. In other words, the photon number decreased when the color intensity increased. The measured digital output of the photon value is shown in Fig. 6(a) for each (11) individual glucose concentration. The experiment was performed thrice, and the average value is given. The photon value was 161 A.U at a low glucose concentration of 110 mg∕dL, and the value linearly decreased to 31 A.U. at the highest concentration of 586 mg∕dL. The change of photon value was linearly correlated to the glucose concentration, and the value was standard and consistent for each experiment. Even small differences of glucose concentrations could change the photon number. The relative oxidation level shown in Fig. 6(b) displays the cumulative value for each concentration of glucose. The relative oxidation level was calculated by subtracting the oxidized glucose value from the chip value. In addition, the CMOS image sensor could measure the glucose levels in mouse whole blood with an accuracy comparable to that of an Accu-Chek sensor, a glucose monitor that is commonly used in diabetes testing. The linearity graph as shown as Fig. 6(c) demonstrates the concentration linearity of the GM9 glucose analyzer and Accu-Chek sensor, whereas Fig. 6(d) shows the linearity of the CMOS image sensor-based photon value to quantify the accuracy. Moreover, the correlation coefficient (R 2 ) value was 0.9675 as a CMOS-based digital output value and 0.9712 for the glucose concentration. The comparison study with other glucose sensors proved the CMOS image sensor-based glucose monitoring system could be applicable for clinical diagnoses to determine blood glucose levels.
Enzyme Activity and Stability Measurements
Analysis of enzyme stability and activity was carried out on the PET chip with five different concentrations of mouse blood glucose. The CMOS image sensor monitored the glucose chip for nonspecific enzyme activity with other sugars. As a result, the assay reagent did not respond with other aqueous sugars and there was no change in color and photon count. The study of nonspecific enzyme activity proved that the glucose chip is very stable and there was no interaction with other nonspecific sugars (data not shown). Subsequently, the chip has been analyzed for thermal stability. The color was developed after 10 min of glucose oxidation due to less kinetic energy at a low temperature of 20°C. However, the assay reagent did not lose stability and the photon count was not influenced at 20°C. The kinetic energy increases when the chip is incubated at 30°C-50°C. Also, the enzyme responded until 70°C and the reaction rate decreased from 50°C because the chip lost the 50% of its stability at 60°C. The chip also decreased its reaction rate at 70°C and lost 90% of its activity. The enzyme denatured at high temperature which leads to a decrease in the reaction rate and an increase in the photon count for the respective concentration of glucose. Figure 7 (a) shows the thermal stability of the glucose chip when using different concentrations of blood glucose and proves the optimum temperature is 30°C-40°C. The kinetic energy was also increased and reached the reaction rate within a few seconds; the color was stable for 30 min. The data was compared with the standard value obtained from the CMOS image sensor and the results showed the consistent digital output value at 20°C -40°C. The enzyme was stable when the chip incubated at 20°C , and it took some time to reach the reaction rate. Small changes in temperature above or below the optimum have not affected the enzyme stability; also, SiO 2 nanoparticles do not uptake high temperature that provides enzyme stability for longer period. Additionally, the pH stability has been analyzed by the CMOS image sensor indicating the glucose oxidation was carried out with different pH ranges (pH 2.0 to 9.0). The reaction rate was increased between pH 4.0 and 6.0, and the enzyme activity was stable in the noted ranges, which produced a consistent photon count. Furthermore, 60% of the enzyme activity lost their function at pH 2.0-3.0 and above pH 8.0. Figure 7(b) shows the photon number increment when the pH was unfavorable for the glucose oxidation. pH stability analysis proved that the optimum pH range was between 4.0 and 6.0 for the glucose chip. The assay reagent started to lose its stability in the range of pH 2.0-3.0 and pH 7.0-9.0, which increased the digital output value. Small changes in pH did not affect the enzyme activity since the bonds can be reformed. In addition, the storage or shelf stability of the glucose chip has been analyzed after 6 months of incubation. Interestingly, the chip was stable until 6 months without any defects in enzyme activity, which was demonstrated the reproducibility in the photon number after a 6-month incubation. Figure 7(c) shows the photon values of different concentrations of whole blood glucose with the 6-month incubated chip. Normally, the enzymes have a possibility of denaturing during long-term storage due to the environmental conditions. However, the amine functionalized enzyme and the controlled storage conditions prevented enzyme denaturation.
Conclusions
A number of studies have been reported for CMOS image sensor-based biological sensing. However, the current study has demonstrated whole blood glucose analysis using a CMOS image sensor via a new approach. Assay reagent immobilized AFSiO 2 nanoparticles were coated with a hydrophilic PET film chip and successfully applied to glucose oxidation. The CMOS image sensor measured the glucose level based on photon number variations. Characterization studies such as UV-spectral analysis, XRD, FTIR, and FE-SEM imagery have proven the accuracy of the sensing method. Moreover, CMOS image sensor-based glucose monitoring has been shown to be highly sensitive, specific, and stable for whole blood glucose sensing. Further study is underway on the CMOS image sensor-based analysis of human whole blood glucose to confirm the standard photon number for each glucose concentration with less blood. Finally, CMOS image sensor-based analysis of whole blood glucose can be successfully introduced into a smart phone for POC diagnosis.
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